{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lidocaine+gel+2%25", "query": { "intervention": "Lidocaine gel 2%" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 62, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lidocaine+gel+2%25&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T23:52:00.932Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02195427", "title": "TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nasolabial Folds, Wrinkles" ], "interventions": [ { "name": "TEOSYAL® RHA Global Action", "type": "DEVICE" }, { "name": "TEOSYAL® RHA Deep Lines", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Teoxane SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 148, "start_date": "2014-06", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-04-25", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Beverly Hills, California • Santa Monica, California + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Chestnut Hill", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02195427" }, { "nct_id": "NCT04754646", "title": "RHA® 4 NLF Cannula", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wrinkle", "Nasolabial Fold", "Aging" ], "interventions": [ { "name": "Split-face injection of RHA® 4 with a cannula into a single NLF.", "type": "DEVICE" }, { "name": "Split-face injection of RHA® 4 with a needle (TSK 27G x ½\") into the contralateral NLF.", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Teoxane SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 50, "start_date": "2021-03-15", "completion_date": "2021-11-29", "has_results": true, "last_update_posted_date": "2023-03-09", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 4, "location_summary": "Encinitas, California • West Palm Beach, Florida • Chapel Hill, North Carolina + 1 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04754646" }, { "nct_id": "NCT02852434", "title": "Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain Management, Cervical Preparation" ], "interventions": [ { "name": "Lidocaine Gel (2%)", "type": "DRUG" }, { "name": "Lidocaine Paracervical Block (1%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 72, "start_date": "2016-07", "completion_date": "2017-04", "has_results": true, "last_update_posted_date": "2019-06-07", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02852434" }, { "nct_id": "NCT01147172", "title": "Safety Study of Cosmetic Tissue Augmentation in People of Color", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wrinkles" ], "interventions": [ { "name": "Elevess", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Anika Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2009-03", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2017-10-17", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 9, "location_summary": "Los Angeles, California • Boca Raton, Florida • Coral Gables, Florida + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Metairie", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147172" }, { "nct_id": "NCT04069585", "title": "RHA® Redensity With New Anesthetic Agent - Perioral Rhytids", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aging", "Pain" ], "interventions": [ { "name": "RHA® Redensity with new anesthetic agent", "type": "DEVICE" }, { "name": "RHA® Redensity with lidocaine", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Teoxane SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 30, "start_date": "2019-10-30", "completion_date": "2020-11-09", "has_results": true, "last_update_posted_date": "2022-01-24", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 3, "location_summary": "Beverly Hills, California • Coral Gables, Florida • Chicago, Illinois", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04069585" }, { "nct_id": "NCT02738203", "title": "Self-Administered Lidocaine Gel for Pain Management With IUD Insertion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "IUD Insertion" ], "interventions": [ { "name": "Vaginal 2% Lidocaine", "type": "DRUG" }, { "name": "Surgical Lubricant Jelly", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 220, "start_date": "2016-06-01", "completion_date": "2017-10-19", "has_results": true, "last_update_posted_date": "2019-06-06", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02738203" }, { "nct_id": "NCT04766996", "title": "PROUD Study - Preventing Opioid Use Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia", "Opioid Use" ], "interventions": [ { "name": "Guided mindfulness exercises", "type": "BEHAVIORAL" }, { "name": "Self-administered aromatherapy", "type": "OTHER" }, { "name": "Baby aspirin", "type": "DRUG" }, { "name": "Tylenol/Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Prilosec", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Voltaren", "type": "DRUG" }, { "name": "Zofran", "type": "DRUG" }, { "name": "Pepcid", "type": "DRUG" }, { "name": "Reglan", "type": "DRUG" }, { "name": "Versed", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Ancef", "type": "DRUG" }, { "name": "Tranexamic Acid (TXA)", "type": "DRUG" }, { "name": "Decadron", "type": "DRUG" }, { "name": "Bupivacaine hydrochloride", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2021-05-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766996" }, { "nct_id": "NCT04536493", "title": "Comparison of 2 Application Techniques for LET Gel Used Prior to Simple Laceration Repair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "LET", "Laceration of Skin" ], "interventions": [ { "name": "LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (1 application)", "type": "DRUG" }, { "name": "LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (3 applications)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Orange County", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Years to 18 Years" }, "enrollment_count": 48, "start_date": "2019-06-19", "completion_date": "2020-06-25", "has_results": false, "last_update_posted_date": "2020-09-02", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04536493" }, { "nct_id": "NCT02517931", "title": "Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postdural Puncture Headache" ], "interventions": [ { "name": "Sphenopalatine Ganglion Block", "type": "PROCEDURE" }, { "name": "Placebo", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-01-01", "completion_date": "2019-09-23", "has_results": false, "last_update_posted_date": "2019-09-25", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02517931" }, { "nct_id": "NCT04203225", "title": "Comparison of Two Application Techniques for LET Gel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lacerations", "Pain, Procedural", "LET" ], "interventions": [ { "name": "LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 48, "start_date": "2017-05-22", "completion_date": "2019-11-12", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-09-28T23:52:00.932Z", "location_count": 2, "location_summary": "Orange, California • Torrance, California", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04203225" } ] }